Top Clinical Trials companies in Germany by Gross Profit Margin
This ranking features the top 6 Clinical Trials companies in Germany ranked by Gross Profit Margin, averaging a Gross Profit Margin of -125.59%, for January 15, 2025.
Germany
Clinical Trials
Gross Profit Margin
# |
Name |
Gross Profit Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
100.00%
|
Dec. 31, 2023 | USD 1.07 | -4.46% |
|
Germany |
|
| 2 |
84.29%
|
Dec. 31, 2023 | USD 116.36 | -0.45% |
|
Germany |
|
| 3 |
56.91%
|
Dec. 31, 2023 | USD 5.29 | 13.28% |
|
Germany |
|
| 4 |
-119.76%
|
Dec. 31, 2023 | USD 5.97 | -4.48% |
|
Germany |
|
| 5 |
-131.34%
|
Dec. 31, 2023 | USD 3.95 | -0.95% |
|
Germany |
|
| 6 |
-743.67%
|
Dec. 31, 2023 | USD 2.34 | NA |
|
Germany |
Frequently Asked Questions
-
Which Clinical Trials company in Germany has the highest Gross Profit Margin ?
The Clinical Trials company in Germany with the highest Gross Profit Margin is Affimed N.V. (NasdaqGM: AFMD) at 100.00%.
-
Which Clinical Trials company in Germany has the lowest Gross Profit Margin ?
The Clinical Trials company in Germany with the lowest Gross Profit Margin is InflaRx N.V. (NasdaqGS: IFRX) at -743.67%.
-
What are the top 10 Clinical Trials companies in Germany by Gross Profit Margin ?
The top 10 Clinical Trials companies in Germany by Gross Profit Margin are Affimed N.V., BioNTech SE, Mainz Biomed B.V., Immatics N.V., CureVac N.V. and InflaRx N.V..
-
What are the bottom 10 Clinical Trials companies in Germany by Gross Profit Margin ?
The bottom 10 Clinical Trials companies in Germany by Gross Profit Margin are InflaRx N.V., CureVac N.V., Immatics N.V., Mainz Biomed B.V., BioNTech SE and Affimed N.V..